{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:22:56Z","timestamp":1787887376179,"version":"build-2784847793"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,15]]},"DOI":"10.1093\/cid\/cis883","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T21:48:42Z","timestamp":1350424122000},"page":"267-270","source":"Crossref","is-referenced-by-count":74,"title":["Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes"],"prefix":"10.1093","volume":"56","author":[{"given":"Elina O.","family":"Erra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Hervius","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutee","family":"Yoksan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Riutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkka","family":"Vene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Vapalahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Kantele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,10,16]]},"reference":[{"key":"key\n\t\t\t\t20170623052636_CIS883C1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20170623052636_CIS883C2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/cid\/cis548","article-title":"Boosting Japanese encephalitis vaccine","volume":"55","author":"Hatz","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623052636_CIS883C3","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170623052636_CIS883C4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/1743-422X-8-449","article-title":"Emergence of Japanese encephalitis virus genotype V in the Republic of Korea","volume":"8","author":"Takhampunya","year":"2011","journal-title":"Virol J"},{"key":"key\n\t\t\t\t20170623052636_CIS883C5","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3201\/eid1411.080542","article-title":"Change in Japanese encephalitis virus distribution, Thailand","volume":"14","author":"Nitatpattana","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170623052636_CIS883C6","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.3201\/eid1712.110914","article-title":"Japanese encephalitis virus genotype replacement, Taiwan, 2009\u20132010","volume":"17","author":"Chen","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170623052636_CIS883C7","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.1128\/JVI.00825-11","article-title":"Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia","volume":"85","author":"Pan","year":"2011","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170623052636_CIS883C8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/cid\/cis542","article-title":"A single dose of Vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines","volume":"55","author":"Erra","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623052636_CIS883C9","first-page":"5205","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004.","volume":"23","author":"Hombach","year":"2005"},{"key":"key\n\t\t\t\t20170623052636_CIS883C10","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.vaccine.2008.05.081","article-title":"Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 six and 12 month results of a multicenter follow-up phase 3 study","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170623052636_CIS883C11","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.vaccine.2009.12.080","article-title":"Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: using PRNT50 as an endpoint for immunogenicity","volume":"28","author":"Reisler","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170623052636_CIS883C12","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.vaccine.2011.01.058","article-title":"Long term immunity following a booster dose of the inactivated Japanese encephalitis vaccine IXIARO(R), IC51","volume":"29","author":"Eder","year":"2011","journal-title":"Vaccine"},{"issue":"suppl 2","key":"key\n\t\t\t\t20170623052636_CIS883C13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0264-410X(00)00041-4","article-title":"Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains","volume":"18","author":"Kurane","year":"2000","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170623052636_CIS883C14","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.vaccine.2004.03.027","article-title":"Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine","volume":"22","author":"Beasley","year":"2004","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170623052636_CIS883C15","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.vaccine.2010.12.108","article-title":"Study on the protective efficacy of SA14\u201314\u20132 attenuated Japanese encephalitis against different JE virus isolates circulating in China","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170623052636_CIS883C16","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1016\/j.vaccine.2011.06.062","article-title":"Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(R)) induced neutralizing antibody titers","volume":"29","author":"Van Gessel","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170623052636_CIS883C17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biologicals.2007.07.002","article-title":"Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines: report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies","volume":"36","author":"Ferguson","year":"2008","journal-title":"Biologicals"},{"key":"key\n\t\t\t\t20170623052636_CIS883C18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/INF.0b013e3181f68e9c","article-title":"Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial","volume":"29","author":"Chokephaibulkit","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170623052636_CIS883C19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4161\/hv.6.12.13057","article-title":"Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults","volume":"6","author":"Nasveld","year":"2010","journal-title":"Hum Vaccin"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/56\/2\/267\/17851185\/cis883.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T20:04:05Z","timestamp":1503432245000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cis883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,16]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,10,16]]},"published-print":{"date-parts":[[2013,1,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cis883","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,16]]}}}